Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 cases.
World J Surg Oncol
; 20(1): 350, 2022 Oct 24.
Article
in En
| MEDLINE
| ID: mdl-36280841
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Peritoneal Neoplasms
/
Pleural Neoplasms
/
Vascular Neoplasms
/
Nucleoplasmins
/
Mesothelioma, Malignant
/
Lung Neoplasms
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
World J Surg Oncol
Year:
2022
Type:
Article
Affiliation country:
China